Crossmark

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848

Crossref DOI link: https://doi.org/10.1136/bmjresp-2015-000113

Published Online: 2016-02-23

Published Print: 2016-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Delaney, Stephen

Biffen, Mark

Maltby, Justine

Bell, John

Asimus, Sara

Aggarwal, Ajay

Kraan, Maarten

Keeling, David
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01818869 at ClinicalTrials.gov

Documents that mention this clinical trial

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
https://doi.org/10.1136/bmjresp-2015-000113

nct01560234 at ClinicalTrials.gov

Documents that mention this clinical trial

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
https://doi.org/10.1136/bmjresp-2015-000113

nct01818869 at ClinicalTrials.gov

Documents that mention this clinical trial

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
https://doi.org/10.1136/bmjresp-2015-000113